FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229070047> ?p ?o ?g. }

• W4229070047 endingPage "55" @default.
• W4229070047 startingPage "55" @default.
• W4229070047 abstract "Compared to the general population, a higher prevalence of substance use has been found among people with fibromyalgia (FM), but little is known about factors related to use of psychoactive stimulants and depressants. Somatic symptoms that are common to the condition could relate to the substance use, either in response to symptom occurrence or to prevent symptom onset. To address these unanswered questions, we examined the temporal associations between substance use (alcohol, nicotine, caffeine, and cannabis) and somatic symptoms (pain, mental fatigue, and physical fatigue) in the daily lives of adults with FM. Adults with FM (N=50; mean age=45±SD; 88% female, 86% white) completed ecological momentary assessments of substance use, pain intensity, and physical/mental fatigue via a smartphone app 5X/day for eight days. Linear-mixed effects models showed that use of nicotine and cannabis were positively associated with concurrent mental fatigue (respectively; B= 12.08; p= 0.003, B= 6.93; p= 0.02); in contrast caffeine consumption was negatively associated with concurrent mental fatigue B= -4.28; p= 0.000. Of the substances examined, only caffeine use showed a significant contemporaneous association with physical fatigue (B= -4.85; p= 0.000) and pain (B= -2.79; p= 0.003). For temporal effects results, substance use was not related to later fatigue or pain ratings. However, higher level of pain intensity predicted higher odds of later cannabis use (B= 0.027; p<0.001). Findings indicated that only alcohol use showed no concurrent/temporal associations with somatic symptoms in FM. When participants reported caffeine use, they also reported lower mental fatigue, physical fatigue, and pain. Mental fatigue was higher when people reported use of nicotine or cannabis. In terms of symptoms predicting later substance use, only increased pain was related to later cannabis use. These findings may inform individualized interventions for symptom management and/or problems related to use of psychoactive substances. National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH (grant K01-AR-064275). Compared to the general population, a higher prevalence of substance use has been found among people with fibromyalgia (FM), but little is known about factors related to use of psychoactive stimulants and depressants. Somatic symptoms that are common to the condition could relate to the substance use, either in response to symptom occurrence or to prevent symptom onset. To address these unanswered questions, we examined the temporal associations between substance use (alcohol, nicotine, caffeine, and cannabis) and somatic symptoms (pain, mental fatigue, and physical fatigue) in the daily lives of adults with FM. Adults with FM (N=50; mean age=45±SD; 88% female, 86% white) completed ecological momentary assessments of substance use, pain intensity, and physical/mental fatigue via a smartphone app 5X/day for eight days. Linear-mixed effects models showed that use of nicotine and cannabis were positively associated with concurrent mental fatigue (respectively; B= 12.08; p= 0.003, B= 6.93; p= 0.02); in contrast caffeine consumption was negatively associated with concurrent mental fatigue B= -4.28; p= 0.000. Of the substances examined, only caffeine use showed a significant contemporaneous association with physical fatigue (B= -4.85; p= 0.000) and pain (B= -2.79; p= 0.003). For temporal effects results, substance use was not related to later fatigue or pain ratings. However, higher level of pain intensity predicted higher odds of later cannabis use (B= 0.027; p<0.001). Findings indicated that only alcohol use showed no concurrent/temporal associations with somatic symptoms in FM. When participants reported caffeine use, they also reported lower mental fatigue, physical fatigue, and pain. Mental fatigue was higher when people reported use of nicotine or cannabis. In terms of symptoms predicting later substance use, only increased pain was related to later cannabis use. These findings may inform individualized interventions for symptom management and/or problems related to use of psychoactive substances. National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH (grant K01-AR-064275)." @default.
• W4229070047 created "2022-05-08" @default.
• W4229070047 creator A5038375928 @default.
• W4229070047 creator A5039709105 @default.
• W4229070047 creator A5040604154 @default.
• W4229070047 date "2022-05-01" @default.
• W4229070047 modified "2023-09-28" @default.
• W4229070047 title "Temporal Associations between Substance Use and Somatic Symptoms in the Daily Lives of People with Fibromyalgia" @default.
• W4229070047 doi "https://doi.org/10.1016/j.jpain.2022.03.206" @default.
• W4229070047 hasPublicationYear "2022" @default.
• W4229070047 type Work @default.
• W4229070047 citedByCount "0" @default.
• W4229070047 crossrefType "journal-article" @default.
• W4229070047 hasAuthorship W4229070047A5038375928 @default.
• W4229070047 hasAuthorship W4229070047A5039709105 @default.
• W4229070047 hasAuthorship W4229070047A5040604154 @default.
• W4229070047 hasBestOaLocation W42290700471 @default.
• W4229070047 hasConcept C118552586 @default.
• W4229070047 hasConcept C126322002 @default.
• W4229070047 hasConcept C2777056318 @default.
• W4229070047 hasConcept C2777831278 @default.
• W4229070047 hasConcept C2778500429 @default.
• W4229070047 hasConcept C2779547902 @default.
• W4229070047 hasConcept C2908647359 @default.
• W4229070047 hasConcept C71924100 @default.
• W4229070047 hasConcept C99454951 @default.
• W4229070047 hasConceptScore W4229070047C118552586 @default.
• W4229070047 hasConceptScore W4229070047C126322002 @default.
• W4229070047 hasConceptScore W4229070047C2777056318 @default.
• W4229070047 hasConceptScore W4229070047C2777831278 @default.
• W4229070047 hasConceptScore W4229070047C2778500429 @default.
• W4229070047 hasConceptScore W4229070047C2779547902 @default.
• W4229070047 hasConceptScore W4229070047C2908647359 @default.
• W4229070047 hasConceptScore W4229070047C71924100 @default.
• W4229070047 hasConceptScore W4229070047C99454951 @default.
• W4229070047 hasIssue "5" @default.
• W4229070047 hasLocation W42290700471 @default.
• W4229070047 hasOpenAccess W4229070047 @default.
• W4229070047 hasPrimaryLocation W42290700471 @default.
• W4229070047 hasRelatedWork W1965157661 @default.
• W4229070047 hasRelatedWork W1965353114 @default.
• W4229070047 hasRelatedWork W2001410683 @default.
• W4229070047 hasRelatedWork W2035881564 @default.
• W4229070047 hasRelatedWork W2080530168 @default.
• W4229070047 hasRelatedWork W2090737464 @default.
• W4229070047 hasRelatedWork W2112617104 @default.
• W4229070047 hasRelatedWork W2224204666 @default.
• W4229070047 hasRelatedWork W326008450 @default.
• W4229070047 hasRelatedWork W2618203562 @default.
• W4229070047 hasVolume "23" @default.
• W4229070047 isParatext "false" @default.
• W4229070047 isRetracted "false" @default.
• W4229070047 workType "article" @default.